Other ferroptosis inducers with clinical trial include Imidazole Ketone Erastin (IKE), which functions in inhibiting the SLC7A11, has been shown to play an important role in the treatment of ferroptosis in some cancers [287, 288], future studies could examine this as a possible target of EC ferroptosis. Here, SLC7A11 is linked to cancer.